CHRISTINA RAYNOR: Open Payments
NPI 1659086387 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,713 in 190 payments from 19 companies in 2025. Trend: 2023 $795 · 2024 $2,489 · 2025 $2,713
Food & beverage: $2,713
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $599 |
| Galderma Laboratories, L.P. | 27 | $471 |
| Janssen Biotech, Inc. | 31 | $363 |
| UCB, Inc. | 25 | $282 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $196 |
| Amgen Inc. | 8 | $177 |
| Novartis Pharmaceuticals Corporation | 7 | $135 |
| Organon LLC | 12 | $99 |
| Regeneron Healthcare Solutions, Inc. | 4 | $73 |
| E.R. Squibb & Sons, L.L.C. | 4 | $64 |
Products named: TREMFYA, SKYRIZI, NEMLUVIO, Bimzelx, RINVOQ, OTEZLA, AKLIEF, Winlevi.
Industry payments across IN — which companies pay providers there.
